[1]
S. Tubic, M. Jozing, S. Ikonov, and B. Vučković, “The influence of tissue plasminogen activator, plasminogen activator inhibitor-1, and thrombin activable fibrinolytic inhibitor on the risk of venous thrombosis: Fibrinolysis and venous thrombosis risk”, Medicinski časopis, vol. 58, no. 3, Feb. 2025, doi: 10.5937/mckg58-52508.